Brief: Gensight Biologics Announces Validation Of LUMEVOQ® Marketing Authorisation Application By EMA

Gensight Biologics SA

03/11/2020 06:36

Nov 3 (Reuters) - GENSIGHT BIOLOGICS SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS REPORTS VALIDATION OF LUMEVOQ®
MARKETING
AUTHORISATION APPLICATION (MAA) BY EUROPEAN MEDICINES AGENCY
    * IS ALSO WORKING TOWARDS SUBMITTING LUMEVOQ®'S BIOLOGICS
LICENSE
APPLICATION (BLA) TO U.S. FOOD AND DRUG ADMINISTRATION (FDA) IN
H2 2021.

Source text for Eikon:  ID:nBw2xz0qla 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))